Search
Searching Content by Michele Adelman from Foley Hoag LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Watch: HIPAA Crimes Webinar – How The New Crime Wave Affects You
Unfortunately, health care providers are the perfect mark for theft and extortion because they have huge amounts of sensitive information and maintain such information in computer databases at risk of infiltration.
United States
3 Jun 2016
2
FDA And Amarin Pharma Reach Milestone Settlement Allowing Off-Label Drug Promotion
A milestone Settlement Agreement was reached March 8, 2016 between the Food and Drug Administration and Amarin Pharma, Inc. that expressly allows Amarin to promote its drug product, Vascepa®, for unapproved – i.e., "off-label" – uses.
United States
31 Mar 2016
3
The First, First Circuit Court To Opine On A Newman Challenge
The facts of the Parigian case at first blush appear to be classic insider trading. There are a group of golfing buddies. One of them is Douglas Parigian and another one is Eric McPhail.
United States
19 May 2015
4
RICO Indictment Of NECC Executives For Acts Of Second-Degree Murder
In December 2014, the United States Attorney for the District of Massachusetts obtained a sweeping indictment that charges business executives of the New England Compounding Center ("NECC") with 25 acts of second-degree murder as predicate offenses under the Racketeer Influenced and Corrupt Organizations ("RICO") Act.
United States
3 Feb 2015
5
State Securities Regulators In Massachusetts And Illinois Survey Investment Advisors On Cybersecurity Practices
State securities regulators in Massachusetts and Illinois sent to investment advisors registered in their respective states a survey on their cybersecurity practices.
United States
16 Jun 2014
6
The SEC’s Power To Take Enforcement Action Against Cybersecurity Violators
The SEC has the power to bring enforcement actions against registered entities that fail to meet cybersecurity requisites.
United States
16 May 2014
7
Bulldog II: SJC Eliminates First Amendment Challenge To Securities Violations Found By The Massachusetts Securities Division
A decision by the Massachusetts Supreme Judicial Court ("SJC") on September 22, 2011, lays to rest the Secretary of the Commonwealth’s finding that a hedge fund manager, Bulldog Investors General Partnership ("Bulldog"), and its principals, violated the Massachusetts Securities Act through its operation of an interactive website that provided investment information to all visitors.
United States
4 Oct 2011
8
Secretary Galvin Proposes Expert Network Regulations For Massachusetts Advisers
Secretary of the Commonwealth William Francis Galvin has proposed regulations to add conditions to the use of "matching or expert network services" by investment advisers which are registered in Massachusetts or operating in Massachusetts within an exemption from registration.
United States
27 Apr 2011
9
Qui Tam? Now More Plaintiffs Will Qualify
An important mechanism for bringing suit against healthcare providers and pharmaceutical and medical device companies – the Qui Tam Action – has been expanded as part of the Patient Protection and Affordable Care Act (Pub. L. No. 111-148) (the "PPACA").
United States
27 Apr 2010
10
Hedge Funds Join "The CEO's Brother-In-Law" As The Target Of Insider Trading Cases
Insider trading cases often have focused on "the CEO's brother-in-law" or similarly situated individuals who used a tidbit passed along at Thanksgiving dinner to make a quick and easy personal profit.
United States
12 Nov 2009
11
Medical Devices Play A Large Role In Massachusetts Health Care Fraud Unit Cases: September 2008 - September 2009
A retrospective review of the cases brought by the Massachusetts U.S. Attorney's Office Health Care Fraud Unit between September 2008 and September 2009 reveals a high number of cases involving medical devices as compared to drugs or other medical products.
United States
1 Sep 2009
12
A Low Dose Prescription: Criminal Prosecution Of Off-Label Drug Promotion
Drug company scientists discover that a rare debilitating disease may be treated with a drug licensed to treat an unrelated ailment.
United States
23 Jan 2008
Links to Result pages
 
1